Alpelisib is a drug used to treat PIK3CA mutated breast cancer, which has progressed or metastasized to nearby areas in the body for both men and women. In order to minimize the side effects and maximize the therapeutic effects of Alpelisib, patients need to strictly follow the instructions of the specialist.